EN 
ES Research
Unit
Dedicated to strengthening scientific progress in
Peru by offering cutting-edge biotechnology solutions
Research Unit
Exclusive Representatives of Miltenyi Biotec in Peru
As the exclusive representatives of Miltenyi Biotec in Peru, we offer the national market a comprehensive portfolio of high-precision technologies, equipment, and reagents; designed to strengthen basic, translational, and clinical research. Our proposal encompasses innovative solutions in key areas such as immunology, cell biology, gene therapy, and personalized medicine; aligned with the highest international standards.
Lines of Work
- Cell Separation and Immunomagnetic Technology (MACS®)
Technology for the precise selection of cell subpopulations, used in stem cell research, immunology, and cell therapy.
- Flow Cytometry and Advanced Imaging
Equipment such as the MACSQuant™ Analyzer and the MACSima™ system enable high-resolution, multiparametric cell analysis.
- Cell Culture and Molecular Analysis
Technology for the precise selection of cell subpopulations, used in stem cell research, immunology, and cell therapy.
- GMP-Certified Reagents and Consumables
For applications requiring high regulatory standards, such as the development of cell and gene therapies.
- Automated Systems for Cell Therapy
Platforms such as CliniMACS Prodigy® enable the processing and controlled manufacturing of cellular products with clinical applications.
- Solutions for Gene Therapy and Therapeutic Apheresis
Technologies for the advanced handling of blood components and support in regenerative medicine.
Research Unit
As the exclusive representatives of Miltenyi Biotec in Peru, we offer the national market a comprehensive portfolio of high-precision technologies, equipment, and reagents designed to strengthen basic, translational, and clinical research. Our proposal includes innovative solutions in key areas such as immunology, cell biology, gene therapy, and personalized medicine, aligned with the highest international standards.
- Global Med Farma Drives R&D Project with Support from CONCYTEC and Strategic Alliance with VC Biotec
Global Med Farma has been selected by CONCYTEC as the winner of a Research and Development (R&D) project focused on the validated cultivation of regulatory T lymphocytes for clinical applications. This important milestone reaffirms our commitment to science and healthcare in the country.
The project will be carried out in collaboration with VC Biotec, a biotechnology company with whom we share the vision of driving advanced solutions from Peru to the world.
Would you like to learn more about our products?
Please fill out the form below with your information and your company's details. Then, if you wish, leave us a comment and click the 'Submit' button. You are important to us and will be attended to as soon as possible.